ERBB2 and neoplasm: Luyeye Mvila G et al. compared a BC series diagnosed in Kinshasa (Africans) with a European series of BC diagnosed in Leuven and found that the first group presented BC at younger ages and mainly ER-negative and HER2-positive tumours, when compared to the Caucasian group.